Evidence-Based Treatment of <i>Pseudomonas aeruginosa</i> Infections: A Critical Reappraisal
Multidrug-resistant (MDR)/extensively drug-resistant (XDR) <i>Pseudomonas aeruginosa</i> is emerging as a major threat related to adverse patient outcomes. The goal of this review is to describe evidence-based empiric and targeted treatment regimens that can be exploited when dealing wit...
Saved in:
Main Authors: | Arta Karruli (Author), Christian Catalini (Author), Chiara D'Amore (Author), Francesco Foglia (Author), Fabio Mari (Author), Arjan Harxhi (Author), Massimiliano Galdiero (Author), Emanuele Durante-Mangoni (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cefiderocol and Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Arta Karruli, et al.
Published: (2023) -
<i>Pseudomonas aeruginosa</i> Biofilm Formation, Infections and Treatments
Published: (2021) -
Treatment Heterogeneity in <i>Pseudomonas aeruginosa</i> Pneumonia
by: Aisling R. Caffrey, et al.
Published: (2022) -
Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022) -
The Basis for Natural Multiresistance to Phage in <i>Pseudomonas aeruginosa</i>
by: Christine Pourcel, et al.
Published: (2020)